Dr. Helen Tremlett is an associate professor in the Faculty of Medicine, Division of Neurology at the University of British Columbia (UBC), and a Canada Research Chair in Neuroepidemiology and Multiple Sclerosis. She is also funded by the MS Society of Canada’s Don Paty Career Development Award and a Michael Smith Foundation for Health Research Scholar Award.
Tremlett holds operating grants from the Canadian Institutes of Health Research, the US National MS Society, and the UK MS Trust. Trained in pharmacoepidemiology/multiple sclerosis with a PhD from Cardiff University (UK), Tremlett heads the Pharmacoepidemiology in MS (PiMS) research group.
Current research interests include the natural history of MS; prognosis and predictors of disease progression in MS; effectiveness of the immunomodulatory drugs (IMDs) in MS; adverse effects of the MS IMDs; pharmacogenomics; MS epidemiology; cancer and MS; pregnancy outcomes and MS; impact of parental MS on childhood developmental outcomes; vitamin D, sunlight, infections, and MS disease activity.
Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J and Tremlett H. Relative mortality and survival in multiple sclerosis: Findings from British Columbia, Canada. Journal of Neurology, Neurosurgery & Psychiatry 2012 Jan;83(1):61-6. Epub 2011 Aug 23
Kingwell E, Bajdik C, Phillips N, Zhu F, Oger J, Hashimoto S, Tremlett H Cancer risk in multiple sclerosis: findings from British Columbia, Canada. Brain. 2012;135:2973-2979
Tremlett H, Zhu F, Petkau, J, Oger J, Zhao Y, and the UBC MS Clinic Neurologists. Natural, innate improvements in multiple sclerosis disability. Multiple Sclerosis Journal. 2012; 18(10):1412-1421
Lu E, Zhao Y, Zhu F, van der Kop ML, Synnes A, Dahlgren L, Sadovnick AD, Sayao AL, Tremlett H; On behalf of the British Columbia Multiple Sclerosis Clinic Neurologists. Birth hospitalization in mothers with multiple sclerosis and their newborns. Neurology. 2013;80:447-452
Shirani, A, Zhao Y, Karim M, Evans C, Kingwell E, van der Kop M, Oger J, Gustafson P, Petkau J, Tremlett H. Association between use of beta-interferon and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA. 2012 Jul 18;308(3):247-56